Dissociation of Its Opposing Immunologic Effects Is Critical for the Optimization of Antitumor CDB+ T-Cell Responses Induced by Interleukin 21

Saved in:
Bibliographic Details
Published inClinical cancer research Vol. 14; no. 19; pp. 6125 - 6136
Main Authors ARISEN, Sascha, BUTLER, Marcus O, BEREZOVSKAYA, Alla, MURRAY, Andrew P, STEVENSON, Kristen, NADLER, Lee M, HIRANO, Naoto
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 2008
Subjects
Antineoplastic agents
Biological and medical sciences
Medical sciences
Pharmacology. Drug treatments
Antineoplastic agent
Immune response
Interleukin 21
Optimization
Online AccessGet full text

Cover

More Information
ISSN:1078-0432
1557-3265